SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 236.48 |
Enterprise Value ($M) | 100.66 |
Book Value ($M) | 544.91 |
Book Value / Share | 9.47 |
Price / Book | 0.43 |
NCAV ($M) | 329.42 |
NCAV / Share | 5.73 |
Price / NCAV | 0.72 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.00 |
Return on Assets (ROA) | 0.00 |
Return on Equity (ROE) | 0.00 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.92 |
Current Ratio | 4.94 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 432.95 |
Assets | 648.44 |
Liabilities | 103.53 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 192.64 |
Operating Income | -13.95 |
Net Income | 2.51 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 12.80 |
Cash from Investing | -12.06 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Renaissance Technologies Llc | 6.40 | 27.40 | |
13G/A | Vanguard Group Inc | 6.01 | -13.43 | |
13G/A | Dimensional Fund Advisors Lp | 3.40 | -31.04 | |
13G/A | BlackRock Inc. | 14.50 | 23.48 | |
13G/A | State Street Corp | 2.13 | -67.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
147,930 | 1,170,206 | 12.64 | |
86,712 | 716,244 | 12.11 | |
50,644 | 604,360 | 8.38 | |
61,905 | 593,607 | 10.43 | |
(click for more detail) |
Similar Companies | |
---|---|
VAXX – Vaxxinity, Inc. | VCEL – Vericel Corporation |
VERA – Vera Therapeutics, Inc. | VRCA – Verrica Pharmaceuticals Inc. |
WVE – Wave Life Sciences Ltd. |
Financial data and stock pages provided by
Fintel.io